David F. Archer, MD |
Eastern Virginia Medical School, Contraceptive Research and Development Program (CONRAD), Norfolk, USA |
Philippe Bouchard, MD |
Hospital St-Antoine and Université Pierre & Marie Curie, National Institute for Biomedical Research, Paris, France |
Donald R. Conklin |
Former President, Pharmaceuticals, Schering-Plough, New Jersey, USA |
J.C. Gallagher, MD |
Professor of Medicine & Director of the Bone Metabolism Unit, Creighton University School of Medicine, Omaha, USA |
Andrea Riccardo Genazzani, MD, PhD |
University of Pisa, International Society of Gynecological Endocrinology, European Society for Gynecologic and Obstetric Investigation, Pisa, Italy |
Alexander R. Giaquinto, PhD |
Former Senior Vice-President, Worldwide Regulatory Affairs, Schering-Plough. New-Jersey, USA |
Martin Godbout, O.C., PhD |
Ex-President and Chief Executive Officer of Genome Canada, Officer of the Order of Canada, Québec, Canada |
Roger Guillemin, M.D., PhD |
The Salk Institute; National Academy of Sciences member; Nobel Prize Laureate in Medicine, San Diego, USA |
Anthony Howell, MD |
University of Manchester, Christie Hospital, Manchester, U.K. |
Thomas Lauda |
Ex-President of the Japan, Latin America, Far East (J-LAFE) Region of Schering-Plough Corporation's Global Pharmaceutical Business |
Wulf H. Utian, MD, PhD |
Case Western Reserve University, Rapid Medical Research, Cleveland Clinic; Past CEO of North American Menopause Society, Cleveland, USA |